Open access · CC-BY
via OpenAlex
Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy
Rebecca Bornstein, Katerina James, Julia Stokes, Kyung Yeon Park, Ernst‐Bernhard Kayser, John Snell, Angela M. Bard, Yihan Chen, Franck K. Kalume, Simon C. Johnson
Neurobiology of Disease · 2021 · ▲ 18 citations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Altered intercellular communication
Rapamycin / mTOR inhibition
Human
Mouse
Preclinical / animal
Abstract
Genetic mitochondrial diseases are the most frequent cause of inherited metabolic disorders and one of the most prevalent causes of heritable neurological disease. Leigh syndrome is the most common clinical presentation of pediatric mitochondrial disease, typically appearing in the first few years of life, and involving severe multisystem pathologies. Clinical care for Leigh syndrome patients is difficult, complicated by the wide range of symptoms including characteristic progressive CNS lesion, metabolic sequelae, and epileptic seizures, which can be intractable to standard management. While no proven therapies yet exist for the underlying mitochondrial disease, a ketogenic diet has led to some reports of success in managing mitochondrial epilepsies, with ketosis reducing seizure risk and severity. The impact of ketosis on other aspects of disease progression in Leigh syndrome has not been studied, however, and a rigorous study of the impact of ketosis on seizures in mitochondrial disease is lacking. Conversely, preclinical efforts have identified the intracellular nutrient signaling regulator mTOR(definition) as a promising therapeutic target, with data suggesting the benefits are mediated by metabolic changes. mTOR inhibition alleviates epilepsies arising from defects in TSC, an mTOR regulator, but the therapeutic potential of mTOR inhibition in seizures related to primary mitochondrial dysfunction(definition) is unknown. Given that ketogenic diet is used clinically in the setting of mitochondrial disease, and mTOR inhibition is in clinical trials for intractable pediatric epilepsies of diverse causal origins, a direct experimental assessment of their effects is imperative. Here, we define the impact of dietary ketosis on survival and CNS disease in the Ndufs4(KO) mouse model of Leigh syndrome and the therapeutic potential of both dietary ketosis and mTOR inhibition on seizures in this model. These data provide timely insight into two important clinical interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.nbd.2021.105594
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Bornstein, R., James, K., Stokes, J., Park, K.Y., Kayser, E., Snell, J., Bard, A.M., Chen, Y., Kalume, F.K., & Johnson, S.C. (2021). Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy. <em>Neurobiology of Disease</em>. https://doi.org/10.1016/j.nbd.2021.105594
Vancouver
Bornstein R, James K, Stokes J, Park KY, Kayser E, Snell J, et al. Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy. Neurobiology of Disease. 2021. doi:10.1016/j.nbd.2021.105594.
BibTeX
@article{rebecca2021Differ,
title = {Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy},
author = {Rebecca Bornstein and Katerina James and Julia Stokes and Kyung Yeon Park and Ernst‐Bernhard Kayser and John Snell and Angela M. Bard and Yihan Chen and Franck K. Kalume and Simon C. Johnson},
journal = {Neurobiology of Disease},
year = {2021},
doi = {10.1016/j.nbd.2021.105594},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Clinical and Translational Neurology 2019
Open access · CC-BY
Exploring mTOR inhibition as treatment for mitochondrial disease
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · CC-BY
Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
Oncotarget 2016
Open access · CC-BY
Rapamycin enhances survival in a Drosophila model of mitochondrial disease
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY
Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh Syndrome
International Journal of Molecular Sciences 2021
Open access · CC-BY